GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4922)

  • GC72852 structure
    GC72852Helenalin acetate
    CAS: 10180-86-6
    Purity: >98.00%

    Helenalin acetate, un inhibiteur naturel de NF-κB, est un puissant inhibiteur de C/EBPβ.

  • GC72858 structure
    GC72858Avenanthramide A
    CAS: 108605-70-5
    Purity: >99.00%

    Avenanthramide A est une ptoalexine que l'on trouve dans l'avoine (Avena sativa L.).

  • GC72862 structure
    GC72862Erasin
    CAS: 2256056-21-8
    Purity: >95.00%

    Erasin est un puissant inhibiteur de STAT3 antagoniste de la résistance à l'erlotinib avec des IC50 de 9,7 et 24 µm pour STAT3 et stat1, respectivement.

  • GC72864 structure
    GC72864PZ703b hydrochloride
    Purity: >99.00%

    PZ703b hydrochloride est un dégradeur PROTAC Bcl-xl qui induit l’apoptose et inhibe la prolifération des cellules cancéreuses.

  • GC72868 structure
    GC72868AZA197
    CAS: 1249398-09-1
    Purity: >98.00%

    AZA197 est un Inhibiteur sélectif de petites molécules de Cdc42.

  • GC72875 structure
    GC72875Justicidin A
    CAS: 25001-57-4
    Purity: >99.00%

    Justicidin A est un produit de la nature qui pourrait être isolé sous Justicia procumbens.

  • GC72878 structure
    GC72878UCD38B hydrochloride
    CAS: 1115177-19-9
    Purity: >99.00%

    UCD38B hydrochloride est un inhibiteur de l’upa enzymatique compétitif par cellules avec une valeur ci50 de 7 μM.

  • GC72888 structure
    GC72888CPS-11
    CAS: 145945-21-7
    Purity: >99.00%

    CPS-11 (n - (droxymetl) Thalidomide), un analogue de la Thalidomide, est un puissant agent anticancéreux.

  • GC72892 structure
    GC72892Oblimersen sodium
    Purity: >98.00%

    Oblimersen sodium est un inhibiteur de BCL-2 ciblant l’arn BCL-2.

  • GC72910 structure
    GC72910DD1
    CAS: 187585-11-1
    Purity: >99.00%

    DD1 inhibiteurs du protéasome ciblant l'activation de Bax et la dégradation de p70s6k lors de l'apoptose dans la leucémie myéloïde aiguë (Lam).

  • GC72915 structure
    GC72915(R)-MRT199665
    Purity: >98.00%

    (R)-MRT199665 est un isomère de MRT199665.

  • GC72924 structure
    GC72924PD173952
    CAS: 305820-75-1
    Purity: >99.00%

    PD173952 est un inhibiteur de tyrosine kinases avec des ci50 de 0,3, 1,7 et 6,6 nM contre Lyn, Abl et Csk, respectivement.

  • GC72928 structure
    GC72928DB818
    CAS: 790241-43-9
    Purity: >98.00%

    DB818 est un puissant inhibiteur de homeobox A9 (hoxa9).

  • GC72929 structure
    GC72929DB818 dihydrochloride

    DB818 dihydrochloride est la forme de sel de didrochlorure de DB818.

  • GC72933 structure
    GC72933LQZ-7F
    CAS: 354543-09-2
    Purity: >97.00%

    LQZ-7F, un inhibiteur de la dimérisation survivin, induit l’apoptose spontanée et synergie avec le docétaxel dans les cellules cancéreuses de la prostate.

  • GC72944 structure
    GC72944MMRi64
    CAS: 430458-66-5
    Purity: >98.00%

    MMRi64 perturbe les interactions Mdm2-MdmX.

  • GC72948 structure
    GC72948Dibenzo(a,i)pyrene
    CAS: 189-55-9
    Purity: >98.00%

    Dibenzo(a,i)pyrene est un Ligand récepteur de la 2,3,7,8 - tétrachlorodibenzodioxine TCDD.

  • GC72956 structure
    GC72956Batifiban TFA
    Purity: >99.00%

    Batifiban TFA Le cyclopeptide est un antagoniste de la glycoprotéine plaquettaire gp₂b / Ⅲa qui inhibe l'agrégation plaquettaire.

  • GC72971 structure
    GC72971INCB3619
    CAS: 791826-72-7
    Purity: >98.00%

    INCB3619 L'IC50 pour adam10 et adam17 est respectivement de 22 nm et 14 nm.

  • GC72984 structure
    GC72984FAPI-2 TFA
    Purity: >98.00%

    FAPI-2 TFA est un inhibiteur de protéine d’activation de fibroblaste (FAP) avec une utilisation potentielle dans la recherche sur le cancer.

  • GC72985 structure
    GC72985Z-LEVD-FMK
    CAS: 1135688-25-3
    Purity: >98.50%

    Z-LEVD-FMK est un inhibiteur de la caspase - 4 perméable aux cellules.

  • GC72987 structure
    GC72987N-Acetyl-D-galactosamine, 98%
    CAS: 14215-68-0
    Purity: >98.00%

    N-Acetyl-D-galactosamine, 98% (galnac) est un aminose terminal essentiel dérivé du galactose, qui forme l'antigène du Groupe sanguin humain a.

  • GC72994 structure
    GC72994RAPTA-C
    CAS: 372948-28-2
    Purity: >99.00%

    RAPTA-C (Ru (η6 - ène) Cl2 (PTA)) est un agent anticancéreux et anti - angiogénique.

  • GC72995 structure
    GC72995MnTE-2-PyP chloride
    CAS: 219818-60-7
    Purity: >95.00%

    MnTE-2-PyP chloride est un récupérateur de ROS et un puissant radioprotecteur.